- Home
- GRVY vs NBY Comparison
GRVY vs NBY Comparison
Compare GRVY & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRVY | NBY |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 398.2M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GRVY | NBY |
|---|---|---|
| Price | $60.20 | $1.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.7K | ★ 817.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | N/A | $23.91 |
| Revenue Next Year | N/A | $32.05 |
| P/E Ratio | $8.05 | ★ $1.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $54.25 | $0.43 |
| 52 Week High | $74.75 | $19.95 |
Technical Indicators
Market Signals| Indicator | GRVY | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 37.28 | 41.39 |
| Support Level | $55.89 | $0.94 |
| Resistance Level | $65.27 | $1.36 |
| Average True Range (ATR) | 2.19 | 0.21 |
| MACD | -0.54 | 0.15 |
| Stochastic Oscillator | 10.03 | 5.87 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.